Working with local, state and Federal officials, Cedars-Sinai is committed to bringing our patients and community timely vaccines and the best healthcare available through the COVI...
Patients who have a critical illness that results in an ICU stay are at risk for continued health complications. To address ICU complications Cedars-Sinai has opened a Post-ICU Cli...
With robotics technology rapidly advancing, Cedars-Sinai is poised to remain a leader in robotic surgical innovation for patients with advanced lung disease. Read more.
Meet Dr. Michael Albert, a staff physician in General Internal Medicine at Cedars-Sinai! A transplant from Oklahoma who loves L.A., Dr. Albert practices what he preaches and believ...
Meet Dr. Pedro Catarino, the new director of Aortic Surgery at Cedars-Sinai. We talked him about joining the Smidt Heart Institute, the latest innovations in heart and lung transpl...
2021 has arrived bringing with it a new wave of hopefulness with the promise of COVID-19 vaccines. While the last year has brought many challenges, we wanted to take a look back at...
The COVID-19 pandemic has reached crisis levels in California. Cedars-Sinai doctors, nurses and healthcare workers are urging you to please stay home on New Year's Eve, do not gath...
Prominent pulmonologists including Cedars-Sinai's Vic Tapson suggest gargling is worthy of further study as a means to prevent COVID-19 in a recent commentary in the American Journ...
As the COVID-19 pandemic continues on and vaccination ramps up, Cedars-Sinai experts reassure IBD patients about their risk of complications and the importance of vaccination. Lear...
While there is currently no data on the safety of COVID-19 vaccines for pregnant or breastfeeding women, health experts believe mRNA vaccines are unlikely to pose a risk for people...
Nurses bring cheer to patients and families spending their holidays in the hospital. Even with the COVID-19 pandemic, they managed decorations, first photos for NICU newborns, and ...
As colorectal cancer rates steadily increase in people under 50, Cedars-Sinai investigators are seeking out better ways to screen younger adults for the disease. Read more.